To determine whether deficiencies or abnormalities in complement system proteins are contributing to increased infections or increased autoimmune activity; to help monitor the activity and treatment of autoimmune diseases and immune complex-related diseases (Complement deficiencies may comprise between 1 and 10% of all primary immunodeficiencies.)
A blood sample drawn from a vein in your arm
The complement system consists of almost 60 proteins, approximately 30 of which are circulating blood proteins that work together to promote immune and inflammatory responses. Complement tests measure the amount or activity of complement proteins in the blood.
The complement system's principal role is to help identify, destroy and remove foreign pathogens like bacteria and viruses, as well as damaged "self" materials (e.g., cells and proteins). The complement system is so named because it “complements” or aids the natural body defenses, such as antibodies. So, the complement system is also activated when the body makes antibodies, whether against itself or foreign invaders. The body makes antibodies against its own tissues that it thinks are foreign (autoantibodies) in various autoimmune diseases.
The complement system is part of the body's innate immune system. Unlike the acquired immune system, which produces antibodies that target and protect against specific threats, the innate immune system is non-specific and can quickly respond to foreign substances. It does not require previous exposure to an invading microbe or offending substance and does not maintain a memory of previous encounters.
There are nine primary complement proteins that are designated C1 through C9. These components, in addition to the remaining proteins, work together in a cascade-like approach by activating, amplifying, breaking apart, and forming protein complexes that respond to infections, "non-self" tissues (e.g., transplants), dead cell debris (e.g., from apoptosis), or inflammation.
The complement cascade consists of 3 separate pathways that may be activated to converge in a final common pathway. The pathways include the "classical pathway" (including components C1qrs, C2, C4), the "alternative pathway" (including components C3, factor B, properdin), and the "lectin pathway" (a.k.a. mannan-binding lectin [MBL]). The end result of all three activation pathways is the same – the formation of the membrane attack complex (MAC). Complement activation causes several things to happen ("complement cascade"):
- The MAC binds to the surface of each microbe, abnormal cell, or substance that has been targeted for destruction. It creates a lesion (hole) in the membrane wall and causes lysis, which is destruction of the cell by letting the contents out – like piercing a water-filled balloon.
- It increases the permeability of blood vessels, allowing infection-fighting white blood cells (WBCs) to move out of the bloodstream and into tissues.
- It attracts WBCs to the site of the infection.
- It stimulates phagocytosis, a process in which microbes are engulfed by macrophages and neutrophils and killed.
- It also labels immune complexes with complement components so that WBCs will engulf them and clear them out of the blood.
Complement tests measure the amount or the function (activity) of complement proteins in the blood. Complement components may be measured individually or together to determine whether the system is functioning normally. C3 and C4 are the most frequently measured complement proteins. Total complement activity can be measured if a healthcare practitioner suspects a deficiency that is not measured by C3 or C4. The CH50 functional test measures the function of the complete classical complement pathway, mediated by components C1 – C9. If this measurement is outside the normal range, then each of the nine different complement levels can be measured individually to look for hereditary or acquired deficiencies.
How is it used?
Complement tests, most commonly C3 and C4, are used to determine whether deficiencies or abnormalities in the complement system are causing, or contributing to, a person's disease or condition. Total complement activity (CH50) may be ordered to look at the integrity of the entire classical complement pathway. Other complement components are ordered as needed to look for deficiencies.
Complement testing may be used to:
- Help diagnose the cause of recurrent microbial infections (such as Streptococcus pneumoniae, Neisseria meningitides, Neisseria gonorrhea), angioedema, or inflammation
- Help diagnose and monitor the activity and treatment of acute or chronic autoimmune diseases such as lupus (systemic lupus erythematosus or SLE) and rheumatoid arthritis
- Monitor immune complex-related diseases and conditions such as glomerulonephritis (a kidney disorder), serum sickness, and vasculitis
When is it ordered?
Complement testing may be ordered when a person has unexplained inflammation or edema or symptoms of an autoimmune disorder such as lupus. It may also be ordered when a healthcare practitioner suspects that someone may have an immune complex-related condition and wants to check the status of the person's complement system.
Individual complement components may be ordered when the total complement activity (CH50, sometimes called CH100) is abnormal to help determine which of the components are deficient or abnormal. C3 and C4 levels are the most frequently ordered, but others, such as C1 inhibitor, may be ordered when other deficiencies are suspected. C3 and C4 are often ordered together as the relative levels are often important.
When an acute or chronic condition has been diagnosed, complement testing may be used to help give a rough idea of the severity of the condition with the assumption that the severity is linked to the decrease in complement levels. Complement testing may also be ordered occasionally when a healthcare practitioner wants to monitor the current activity of a condition.
What does the test result mean?
Complement levels may be decreased due to increased consumption (because of increased activation) or, more rarely, a hereditary deficiency. Hereditary deficiency in one of the complement proteins will usually lead to a high frequency of recurrent microbial infections. Decreased complement levels also are associated with an increased risk of developing an autoimmune disease. Both C3 and C4 levels are typically depressed in lupus while C3 alone is low in septicemia and infections caused by fungi or parasites such as malaria.
Decreased complement activity may be seen with:
- Recurrent microbial infections (usually bacterial)
- Autoimmune diseases, including lupus and rheumatoid arthritis
- Hereditary angioedema
- Acquired angioedema
- Various types of kidney disease, including glomerulonephritis, lupus nephritis, membranous nephritis, and IgA nephropathy as well as kidney transplant rejection
- Septicemia, shock
- Serum sickness (immune complex disease)
Complement protein levels are usually increased, along with other unrelated proteins called acute phase reactants, during acute or chronic inflammation. These all usually return to normal when the underlying condition is resolved. However, complement proteins are rarely measured in these conditions, compared to the widely ordered C-reactive protein (CRP), and the relevance of their measurement in these situations is not reviewed here.
Increased complement activity may also be seen with:
Is there anything else I should know?
What are the other parts of the innate immune system?
- The phagocytic system (white blood cells, including neutrophils and monocytes/macrophages), whose function is to ingest and digest invading microbes
- Inflammatory mediators produced by various cells, including basophils, mast cells, and eosinophils
- Natural killer (NK), B and T cells that are specialized lymphocytes that kill some tumors cells, microorganisms, and cells that have been infected by viruses
- Acute phase reactants and cytokines, which are a group of soluble proteins that can cause changes in the growth of many cells, including the white blood cells that produce them